Evidence map›Paper›PMID 25771167›Full record

ArticleNeurobiology of disease2015

The BDNF Val66Met variant affects gene expression through miR-146b.

Pei-Ken Hsu, Bin Xu, Jun Mukai, Maria Karayiorgou, Joseph A Gogos

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. miRNA regulation of social and anxiety-related behaviour.Cellular and molecular life sciences : CMLS · 2020
    Review
  7. Article
  8. Review
  9. Genetic epistasis regulates amyloid deposition in resilient aging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017
    Article
  10. Article
  11. Neurobiology of local and intercellular BDNF signaling.Pflugers Archiv : European journal of physiology · 2017
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pei-Ken HsuDepartment of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.
Bin XuDepartment of Psychiatry, Columbia University, New York, NY, USA.
Jun MukaiDepartment of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.
Maria KarayiorgouDepartment of Psychiatry, Columbia University, New York, NY, USA. Electronic address: mk2758@columbia.edu.
Joseph A GogosDepartment of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA; Department of Neuroscience, Columbia University, New York, NY, USA. Electronic address: jag90@columbia.edu.
Columbia University · US

Funding

Functional Analysis of the 22q11.2 schizophrenia susceptibility genesR01MH067068 · NIMH · ROCKEFELLER UNIVERSITY · PI KARAYIORGOU, MARIA · 2003 to 2017
$7.5M
MicroRNA Dysregulation in Pyschiatric Disorders and Cognitive DysfunctionR01MH097879 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2012 to 2021
$5.4M
Elucidation of gene networks underlying susceptibility to schizophreniaR01MH077235 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2007 to 2009
$1.3M
NIMH NIH HHS MH077235NIMH NIH HHS MH67068NIMH NIH HHS MH97879NIMH NIH HHS R01 MH067068NIMH NIH HHS R01 MH077235NIMH NIH HHS R01 MH097879
6 · The paper itself

Abstract

Variation in gene expression is an important mechanism underlying susceptibility to complex disease and traits. Single nucleotide polymorphisms (SNPs) account for a substantial portion of the total detected genetic variation in gene expression but how exactly variants acting in trans modulate gene expression and disease susceptibility remains largely unknown. The BDNF Val66Met SNP has been associated with a number of psychiatric disorders such as depression, anxiety disorders, schizophrenia and related traits. Using global microRNA expression profiling in hippocampus of humanized BDNF Val66Met knock-in mice we showed that this variant results in dysregulation of at least one microRNA, which in turn affects downstream target genes. Specifically, we show that reduced levels of miR-146b (mir146b), lead to increased Per1 and Npas4 mRNA levels and increased Irak1 protein levels in vitro and are associated with similar changes in the hippocampus of hBDNF(Met/Met) mice. Our findings highlight trans effects of common variants on microRNA-mediated gene expression as an integral part of the genetic architecture of complex disorders and traits.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsBrain-Derived Neurotrophic FactorGene Expression RegulationHippocampusHumansInterleukin-1 Receptor-Associated KinasesIn Vitro TechniquesMethionineMiceMice, TransgenicMicroRNAsMolecular Sequence DataPeriod Circadian ProteinsValineBasic Helix-Loop-Helix ProteinsBrain-Derived Neurotrophic FactorInterleukin-1 Receptor-Associated KinasesIrak1 protein, mouseMethionineMicroRNAsMirn146 microRNA, mouseNpas4 protein, mousePer1 protein, mousePeriod Circadian ProteinsValineBDNFKnock-in miceMicroRNAVal66Met

Identifiers

PMID25771167
PMCPMC5579022
OpenAlexW1989535495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.